Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.
about
Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis.Cancer immunopreventionEmbryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene.Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma.The antigenic repertoire of premalignant and high-risk lesions.DNA vaccines in veterinary use.Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapyAntitumor immunopreventive effect in mice induced by DNA vaccine encoding a fusion protein of alpha-fetoprotein and CTLA4.Preclinical HER-2 Vaccines: From Rodent to Human HER-2A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease.Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis.DNA vaccination: using the patient's immune system to overcome cancerAnalysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model.HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination.Imiquimod and S-27609 as adjuvants of DNA vaccination in a transgenic murine model of HER2/neu-positive mammary carcinoma.HER2 peptide-specific CD8(+) T cells are proportionally detectable long after multiple DNA vaccinations.Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.
P2860
Q24796792-0ACBEFC7-D4D2-4A94-828D-03037E36D328Q28303393-702BB765-30BC-4A37-92FF-6E60B1B4C187Q30403182-9414346A-432A-45CC-A397-8DABED479E0AQ35083847-EF9F26E5-D605-42B0-86D0-BBC73F94CC4FQ35147489-A6FD894E-0550-4599-9D23-3989F41B3539Q35251460-6B8C4FC3-C7C7-4580-9934-373EC33AC1C2Q35586830-6BBBD715-C3CE-40B7-8F46-9430CB9746E2Q36116250-55DBB2E4-A00E-45BF-BDE8-0E51AE0A966BQ36474380-CCBAC169-9E72-4507-844E-B5C14940F9FAQ36914661-80FD1D89-31FB-40F7-9BCC-6BE89C80A13DQ37396281-9D4A48F2-61BD-4DE4-AA0A-5352FD8BCFC1Q37644937-4A328484-60A1-4205-A084-BE1AD42AB76EQ37825422-7DF52357-70E4-4168-9A1C-93E985CD7516Q39658273-5D96EE64-659D-401E-9DDE-F086C7C3B101Q45858638-4DA882B8-4B14-4490-BE21-F1AD8836484CQ45884086-6F984D66-05B4-4291-9787-AA40F3C09C86Q45887207-F40C85D0-023F-4AFF-A38E-C0FBD8CF2DA5Q53482870-385085FD-ACF4-45EE-9296-D015CB5FB3A6
P2860
Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Prevention of spontaneous neu- ...... proto-neu by DNA vaccination.
@en
Prevention of spontaneous neu- ...... proto-neu by DNA vaccination.
@nl
type
label
Prevention of spontaneous neu- ...... proto-neu by DNA vaccination.
@en
Prevention of spontaneous neu- ...... proto-neu by DNA vaccination.
@nl
prefLabel
Prevention of spontaneous neu- ...... proto-neu by DNA vaccination.
@en
Prevention of spontaneous neu- ...... proto-neu by DNA vaccination.
@nl
P2093
P2860
P50
P356
P1433
P1476
Prevention of spontaneous neu- ...... t proto-neu by DNA vaccination
@en
P2093
P2860
P2888
P356
10.1038/SJ.GT.3301360
P577
2001-01-01T00:00:00Z
P5875
P6179
1035961098